ArticlePloS one2026
Mathematical modeling of glucose regulation and sleep resting heart rate to predict risk of metabolic dysregulation in cancer survivors.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sleep-related alterations in glucose metabolism and autonomic regulation play a critical role in the early development of type 2 diabetes mellitus (T2DM), especially among cancer survivors. Motivated by this interplay, we develop a physiologically informed mathematical model linking nocturnal glucose levels with resting heart rate dynamics. The model comprises of a coupled system of ordinary differential equations, and is fitted to wearable sensor data using particle swarm optimization. Sensitivity analysis is carried out to obtain the key parameters driving metabolic dysregulation, enabling the formulation of a personalized risk score. Successful validation using synthetic patient data and cancer survivor patient data suggests that this framework provides a non-invasive, interpretable tool for early T2DM risk stratification based on nocturnal physiological patterns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.